Despite significant progress in reducing the burden of malaria, the disease kills more than 400,000 people each year, most of them children under five. And it robs the continent of billions of dollars in lost productivity annually. As a major employer and investor in many malaria-endemic countries, ExxonMobil has witnessed the devastation of malaria firsthand. We’ve seen its impact on the lives of employees, their families and their communities. That’s why we are part of an international effort to prevent, treat and cure this deadly disease.
ExxonMobil has partnered with the world’s leading organizations that work on the front-lines in the fight against malaria. Together, we are collaborating on four fronts.
Education and capacity-building
Using vital information about prevention and treatment to help build capacity among health workers and inform policies to protect vulnerable communities.
Support for next-generation global health leaders
Fostering the next generation of leaders to take on malaria and other diseases through scholarships and training opportunities.
Prevention, diagnosis, control and elimination
Providing families with the tools to prevent, diagnose and treat malaria, including insecticide-treated bed nets, malaria chemoprophylaxis for pregnant women, rapid diagnostic tests and antimalarial drugs. Access to and effective use of these tools is critical to driving malaria elimination efforts.
Research and development
Supporting the work of researchers who are addressing antimalarial resistance and developing new drugs and vaccines.